Alfred Tinger, MD
Radiation Oncology · Yonkers, NYNPI 1760470173
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,975 of the $3,771 with a category attached, or 78.9%. It is spread thinly across 22 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,018 and has fallen 87.4% since, to $128 in 2025.
Across 50 payments — averaging $75.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Carl Zeiss Meditec, Inc.$790
- Sanofi$387
- Lilly USA, LLC$299
- Novocure Inc.$289
- E.r. Squibb & Sons, L.L.C.$279
- Astellas Pharma US Inc$270
- plus $1K from 16 others
Across 2 payments — averaging $7680.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novocure Inc.$15K
What the payments were for
- Travel & lodging$79021%
- Food & beverage$2,97579%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Carl Zeiss Meditec, Inc. | 1 | $790 |
| Sanofi | 5 | $387 |
| Lilly USA, LLC | 3 | $299 |
| Novocure Inc. | 4 | $289 |
| E.r. Squibb & Sons, L.L.C. | 7 | $279 |
| Astellas Pharma US Inc | 4 | $270 |
| Pfizer | 3 | $257 |
| Eisai Inc. | 2 | $233 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $142 |
| Incyte Corporation | 1 | $125 |
| Varian Medical Systems, Inc. | 1 | $104 |
| Exelixis Inc. | 1 | $93 |
| Novartis | 4 | $89 |
| Sirtex Medical Inc | 1 | $86 |
| Genentech USA, Inc. | 1 | $60 |
| Merck | 3 | $56 |
| AstraZeneca | 1 | $48 |
| Daiichi Sankyo Inc. | 1 | $46 |
| Bristol Myers Squibb | 1 | $43 |
| Johnson & Johnson | 2 | $31 |
| Myriad Genetic Laboratories, Inc. | 1 | $23 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,771 in reported general payments places this provider in the 80th percentile of 397 radiation oncology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tamsulosin Hcl | 34 | $513 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 14 | $427 |
| Bicalutamide | 28 | $396 |
| Dexamethasone | 13 | $229 |
| Lidocaine Hcl ViscousLidocaine Hcl | 13 | $188 |
| Gabapentin | 15 | $166 |
| Paroxetine Hcl | 13 | $51 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 18 | $47 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Yonkers
- Chung ChungSyracuse$3.1M
- Michael ZelefskyNew York$946K
- Jeffrey BogartSyracuse$772K
- Steven FinkelsteinSyracuse$578K
- Shawn ZimbergPlainview$411K
- Edward ObedianOyster Bay$391K
- Nancy LeeNew York$233K
- Dheerendra PrasadBuffalo$178K
- Robert SamsteinNew York$125K
- Jalal AhmedNew York$100K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.